JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $451,308 | -15.7% | 243,950 | -49.4% | 0.08% | -28.8% |
| Q4 2022 | $535,520 | +79.7% | 482,450 | +278.9% | 0.12% | +63.9% |
| Q3 2022 | $298,000 | -45.2% | 127,331 | -29.1% | 0.07% | -43.3% |
| Q2 2022 | $544,000 | -68.3% | 179,531 | -29.0% | 0.13% | -61.9% |
| Q1 2022 | $1,717,000 | -35.0% | 252,831 | -20.0% | 0.33% | -25.7% |
| Q4 2021 | $2,640,000 | +25.9% | 316,175 | +12.0% | 0.45% | +17.6% |
| Q3 2021 | $2,097,000 | +1755.8% | 282,250 | +1600.3% | 0.38% | +1714.3% |
| Q2 2021 | $113,000 | -43.8% | 16,600 | -15.3% | 0.02% | -47.5% |
| Q1 2021 | $201,000 | – | 19,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |